Cancers 2011, 3(4), 4139-4150; doi:10.3390/cancers3044139
Sarcoma Immunotherapy
1
Departments of Oncology, Huntsman Cancer Institute at the University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
2
Departments of Orthopaedic Surgery, Huntsman Cancer Institute at the University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
*
Author to whom correspondence should be addressed.
Received: 6 September 2011 / Revised: 19 October 2011 / Accepted: 19 October 2011 / Published: 10 November 2011
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy)
View Full-Text
|
Download PDF [184 KB, uploaded 10 November 2011]
Abstract
Much of our knowledge regarding cancer immunotherapy has been derived from sarcoma models. However, translation of preclinical findings to bedside success has been limited in this disease, though several intriguing clinical studies hint at the potential efficacy of this treatment modality. The rarity and heterogeneity of tumors of mesenchymal origin continues to be a challenge from a therapeutic standpoint. Nonetheless, sarcomas remain attractive targets for immunotherapy, as they can be characterized by specific epitopes, either from their mesenchymal origins or specific alterations in gene products. To date, standard vaccine trials have proven disappointing, likely due to mechanisms by which tumors equilibrate with and ultimately escape immune surveillance. More sophisticated approaches will likely require multimodal techniques, both by enhancing immunity, but also geared towards overcoming innate mechanisms of immunosuppression that favor tumorigenesis. View Full-TextKeywords:
sarcoma; immunotherapy; immunosurveillance; vaccine
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Gouw, L.G.; Jones, K.B.; Sharma, S.; Randall, R.L. Sarcoma Immunotherapy. Cancers 2011, 3, 4139-4150.